HOWL today
$0.99+$0.02 (+1.95%)close Nov 11, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourLeaning Bullish
15 minBullish
5 minStrong Bearish
Daily trend turns down below $0.95
Key levels
Resistance$1.10
Resistance$1.02
Support$0.95
Support$0.88
Latest news & SEC filings
ProductWerewolf Therapeutics Releases Study Results for Two Candidates
All HOWL news →About Werewolf Therapeutics
Werewolf Therapeutics is a biopharmaceutical company that engineers drugs intended to trigger the body's immune response against cancer and other immune-related diseases. Its PREDATOR technology creates molecules that stay inactive in the bloodstream and become active once they reach a tumor. Its main candidates include WTX-124, an IL-2 therapy, and WTX-330, an IL-12 therapy, both tested in patients with advanced solid tumors. It also develops T cell engagers and has licensed an interferon alpha candidate to Jazz Pharmaceuticals.
Based on the company's 10-K filed Mar 27, 2026.
Nasdaq · Healthcare
Werewolf Therapeutics, Inc. (HOWL)
What Is the Price Target for HOWL?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is HOWL a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HOWL.
Start Free Trial →Is HOWL Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B
Fair Value
$0.91
7
Moat Score
NONE
1/9
Piotroski Score
-11.5
Altman Z-Score
What Is Smart Money Doing with HOWL?
Insider Signal
SELLING
0 buys / 20 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
UNCHANGED
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10% owner | Sale | 245,066 | $93K | Jun 11, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 10% owner | Sale | 17,437 | $7K | Jun 11, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 10% owner | Sale | 42,872 | $16K | Jun 10, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 10% owner | Sale | 3,051 | $1K | Jun 10, 2026 |
| EVNIN LUKE | director | Sale | 76,928 | $28K | Jun 9, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 10% owner | Sale | 345,235 | $128K | Jun 9, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 10% owner | Sale | 24,565 | $9K | Jun 9, 2026 |
| EVNIN LUKE | director | Sale | 60,547 | $24K | Jun 8, 2026 |
| EVNIN LUKE | director | Sale | 24,946 | $10K | Jun 5, 2026 |
| EVNIN LUKE | director | Sale | 20,072 | $9K | Jun 4, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →HOWL Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
18.4%
FCF Growth YoY
-6.8%
Revenue Trend
UNKNOWN
Dark Pool Trades for HOWL
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for HOWL, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:52:04 | $0.98 | 2,500 | $$2K | BUY |
| 19:53:27 | $0.98 | 1,898 | $$2K | SELL |
| 18:51:10 | $0.98 | 5,102 | $$5K | SELL |
| 18:04:31 | $0.98 | 2,500 | $$2K | BUY |
| 17:57:26 | $0.98 | 2,000 | $$2K | BUY |
5 dark pool trades shown · $$14K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Werewolf Therapeutics, Inc. (HOWL) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (8 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HOWL — frequently asked questions
What is HOWL stock price today?
Werewolf Therapeutics, Inc. (HOWL) is at $0.99, up 1.95% (+$0.02) at the Nov 11, 2026 close.
Why is HOWL stock moving today?
Latest HOWL news — Nov 10, 2026: Werewolf Therapeutics Releases Study Results for Two Candidates
What do analysts rate HOWL?
Analyst ratings for HOWL: 2 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did HOWL beat earnings?
HOWL last reported on Jul 31, 2026: EPS $0.08 vs -$0.29 expected — a beat of 127.6%.
Does HOWL pay a dividend?
HOWL does not currently pay a dividend.
What are HOWL support and resistance levels?
Support: $0.95, $0.88, $0.81. Resistance: $1.02, $1.10, $1.20.
What are insiders doing with HOWL?
Insider activity: SELLING, 0 buys and 20 sells in the last 90 days.
What is the latest news on HOWL?
Nov 10, 2026: Werewolf Therapeutics Releases Study Results for Two Candidates